nodes	percent_of_prediction	percent_of_DWPC	metapath
Vincristine—muscle cancer—ocular cancer	0.273	0.381	CtDrD
Vincristine—peripheral nervous system neoplasm—ocular cancer	0.226	0.316	CtDrD
Vincristine—sarcoma—ocular cancer	0.218	0.304	CtDrD
Vincristine—ABCC1—Dactinomycin—ocular cancer	0.079	0.35	CbGbCtD
Vincristine—ABCG2—Dactinomycin—ocular cancer	0.0529	0.234	CbGbCtD
Vincristine—ABCC2—Carboplatin—ocular cancer	0.0393	0.174	CbGbCtD
Vincristine—ABCG2—Carboplatin—ocular cancer	0.0356	0.157	CbGbCtD
Vincristine—ABCB1—Dactinomycin—ocular cancer	0.0191	0.0844	CbGbCtD
Vincristine—Venoocclusive liver disease—Dactinomycin—ocular cancer	0.00266	0.229	CcSEcCtD
Vincristine—Extravasation—Carboplatin—ocular cancer	0.00111	0.0958	CcSEcCtD
Vincristine—Multi-organ failure—Dactinomycin—ocular cancer	0.0011	0.0952	CcSEcCtD
Vincristine—TUBA4A—pineal body—ocular cancer	0.000901	0.184	CbGeAlD
Vincristine—Myelosuppression—Dactinomycin—ocular cancer	0.000767	0.0662	CcSEcCtD
Vincristine—Febrile neutropenia—Dactinomycin—ocular cancer	0.000598	0.0516	CcSEcCtD
Vincristine—Extravasation—Dactinomycin—ocular cancer	0.000412	0.0356	CcSEcCtD
Vincristine—Infection—Carboplatin—ocular cancer	0.000343	0.0296	CcSEcCtD
Vincristine—Mouth ulceration—Dactinomycin—ocular cancer	0.000325	0.0281	CcSEcCtD
Vincristine—Pain—Carboplatin—ocular cancer	0.000295	0.0255	CcSEcCtD
Vincristine—Hepatic failure—Dactinomycin—ocular cancer	0.00029	0.0251	CcSEcCtD
Vincristine—TUBA4A—eye—ocular cancer	0.000274	0.0558	CbGeAlD
Vincristine—Body temperature increased—Carboplatin—ocular cancer	0.000273	0.0236	CcSEcCtD
Vincristine—TUBA4A—retina—ocular cancer	0.000271	0.0553	CbGeAlD
Vincristine—RALBP1—eye—ocular cancer	0.000258	0.0526	CbGeAlD
Vincristine—RALBP1—retina—ocular cancer	0.000256	0.0522	CbGeAlD
Vincristine—TUBB3—lymphoid tissue—ocular cancer	0.000254	0.0518	CbGeAlD
Vincristine—TUBA4A—epithelium—ocular cancer	0.00025	0.0511	CbGeAlD
Vincristine—Aspartate aminotransferase increased—Dactinomycin—ocular cancer	0.000235	0.0203	CcSEcCtD
Vincristine—TUBB4A—eye—ocular cancer	0.000219	0.0447	CbGeAlD
Vincristine—TUBB4A—retina—ocular cancer	0.000217	0.0443	CbGeAlD
Vincristine—Pancytopenia—Dactinomycin—ocular cancer	0.000214	0.0185	CcSEcCtD
Vincristine—TUBB2B—eye—ocular cancer	0.000212	0.0432	CbGeAlD
Vincristine—Neutropenia—Dactinomycin—ocular cancer	0.000211	0.0182	CcSEcCtD
Vincristine—TUBB2B—retina—ocular cancer	0.00021	0.0429	CbGeAlD
Vincristine—Pneumonia—Dactinomycin—ocular cancer	0.000202	0.0175	CcSEcCtD
Vincristine—TUBB2A—eye—ocular cancer	0.000199	0.0407	CbGeAlD
Vincristine—Stomatitis—Dactinomycin—ocular cancer	0.000196	0.0169	CcSEcCtD
Vincristine—TUBA4A—lymphoid tissue—ocular cancer	0.000193	0.0393	CbGeAlD
Vincristine—TUBB6—epithelium—ocular cancer	0.00018	0.0367	CbGeAlD
Vincristine—TUBB4B—eye—ocular cancer	0.000171	0.0349	CbGeAlD
Vincristine—TUBB4B—retina—ocular cancer	0.000169	0.0346	CbGeAlD
Vincristine—Alopecia—Dactinomycin—ocular cancer	0.00016	0.0138	CcSEcCtD
Vincristine—TUBB4A—lymphoid tissue—ocular cancer	0.000154	0.0315	CbGeAlD
Vincristine—Anaemia—Dactinomycin—ocular cancer	0.000145	0.0125	CcSEcCtD
Vincristine—Leukopenia—Dactinomycin—ocular cancer	0.000141	0.0121	CcSEcCtD
Vincristine—TUBB6—lymphoid tissue—ocular cancer	0.000139	0.0283	CbGeAlD
Vincristine—Myalgia—Dactinomycin—ocular cancer	0.000134	0.0116	CcSEcCtD
Vincristine—Oedema—Dactinomycin—ocular cancer	0.000128	0.0111	CcSEcCtD
Vincristine—Infection—Dactinomycin—ocular cancer	0.000127	0.011	CcSEcCtD
Vincristine—Thrombocytopenia—Dactinomycin—ocular cancer	0.000126	0.0108	CcSEcCtD
Vincristine—Anorexia—Dactinomycin—ocular cancer	0.000122	0.0106	CcSEcCtD
Vincristine—ABCC10—lymphoid tissue—ocular cancer	0.000121	0.0248	CbGeAlD
Vincristine—TUBB4B—lymphoid tissue—ocular cancer	0.00012	0.0246	CbGeAlD
Vincristine—Musculoskeletal discomfort—Dactinomycin—ocular cancer	0.000117	0.0101	CcSEcCtD
Vincristine—Decreased appetite—Dactinomycin—ocular cancer	0.000112	0.00963	CcSEcCtD
Vincristine—Fatigue—Dactinomycin—ocular cancer	0.000111	0.00955	CcSEcCtD
Vincristine—Pain—Dactinomycin—ocular cancer	0.00011	0.00947	CcSEcCtD
Vincristine—Gastrointestinal pain—Dactinomycin—ocular cancer	0.000105	0.00906	CcSEcCtD
Vincristine—Abdominal pain—Dactinomycin—ocular cancer	0.000101	0.00875	CcSEcCtD
Vincristine—Body temperature increased—Dactinomycin—ocular cancer	0.000101	0.00875	CcSEcCtD
Vincristine—Hypersensitivity—Dactinomycin—ocular cancer	9.45e-05	0.00816	CcSEcCtD
Vincristine—Asthenia—Dactinomycin—ocular cancer	9.2e-05	0.00795	CcSEcCtD
Vincristine—Diarrhoea—Dactinomycin—ocular cancer	8.78e-05	0.00758	CcSEcCtD
Vincristine—Vomiting—Dactinomycin—ocular cancer	8.16e-05	0.00704	CcSEcCtD
Vincristine—Rash—Dactinomycin—ocular cancer	8.09e-05	0.00698	CcSEcCtD
Vincristine—Nausea—Dactinomycin—ocular cancer	7.62e-05	0.00658	CcSEcCtD
Vincristine—TUBB4B—Metabolism of proteins—RPL39—ocular cancer	7.42e-05	0.00185	CbGpPWpGaD
Vincristine—TUBB4B—Cell Cycle—CDC25A—ocular cancer	7.34e-05	0.00183	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—E2F4—ocular cancer	7.3e-05	0.00182	CbGpPWpGaD
Vincristine—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—ocular cancer	7.29e-05	0.00182	CbGpPWpGaD
Vincristine—TUBB4B—Cell Cycle, Mitotic—CCND3—ocular cancer	7.27e-05	0.00181	CbGpPWpGaD
Vincristine—TUBA4A—Cell Cycle, Mitotic—CCND2—ocular cancer	7.23e-05	0.0018	CbGpPWpGaD
Vincristine—TUBA4A—Cell Cycle, Mitotic—HDAC1—ocular cancer	7.23e-05	0.0018	CbGpPWpGaD
Vincristine—TUBB4B—Cell Cycle—TFDP1—ocular cancer	7.17e-05	0.00179	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—RBL1—ocular cancer	7.16e-05	0.00178	CbGpPWpGaD
Vincristine—TUBB—Cell Cycle, Mitotic—CDK6—ocular cancer	7.15e-05	0.00178	CbGpPWpGaD
Vincristine—TUBB4A—Cell Cycle—CCND3—ocular cancer	7.11e-05	0.00177	CbGpPWpGaD
Vincristine—TUBA4A—Hemostasis—HDAC1—ocular cancer	6.85e-05	0.00171	CbGpPWpGaD
Vincristine—RALBP1—EGF/EGFR Signaling Pathway—HRAS—ocular cancer	6.71e-05	0.00167	CbGpPWpGaD
Vincristine—NR0B1—Gene Expression—MAML2—ocular cancer	6.63e-05	0.00165	CbGpPWpGaD
Vincristine—TUBB4B—Cell Cycle—CCND3—ocular cancer	6.5e-05	0.00162	CbGpPWpGaD
Vincristine—TUBA4A—Cell Cycle, Mitotic—CDKN2B—ocular cancer	6.48e-05	0.00161	CbGpPWpGaD
Vincristine—TUBA4A—Cell Cycle—HDAC1—ocular cancer	6.47e-05	0.00161	CbGpPWpGaD
Vincristine—TUBA4A—Cell Cycle—CCND2—ocular cancer	6.47e-05	0.00161	CbGpPWpGaD
Vincristine—TUBB—Cell Cycle—CDK6—ocular cancer	6.39e-05	0.00159	CbGpPWpGaD
Vincristine—TUBB4A—G2/M Transition—EP300—ocular cancer	6.39e-05	0.00159	CbGpPWpGaD
Vincristine—ABCB1—Integrated Pancreatic Cancer Pathway—E2F4—ocular cancer	6.37e-05	0.00159	CbGpPWpGaD
Vincristine—TUBB4A—Mitotic G2-G2/M phases—EP300—ocular cancer	6.3e-05	0.00157	CbGpPWpGaD
Vincristine—ABCG2—Fluoropyrimidine Activity—TP53—ocular cancer	6.29e-05	0.00157	CbGpPWpGaD
Vincristine—ABCB1—Integrated Pancreatic Cancer Pathway—RBL1—ocular cancer	6.25e-05	0.00156	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—E2F3—ocular cancer	6.21e-05	0.00155	CbGpPWpGaD
Vincristine—TUBB—Cell Cycle, Mitotic—HDAC1—ocular cancer	6.15e-05	0.00153	CbGpPWpGaD
Vincristine—TUBB—Cell Cycle, Mitotic—CCND2—ocular cancer	6.15e-05	0.00153	CbGpPWpGaD
Vincristine—SLC22A3—Metabolism—PSPH—ocular cancer	6.02e-05	0.0015	CbGpPWpGaD
Vincristine—TUBA4A—Cell Cycle, Mitotic—E2F1—ocular cancer	5.95e-05	0.00148	CbGpPWpGaD
Vincristine—TUBB4A—Cell Cycle, Mitotic—CDK6—ocular cancer	5.93e-05	0.00148	CbGpPWpGaD
Vincristine—RALBP1—EGF/EGFR Signaling Pathway—AKT1—ocular cancer	5.92e-05	0.00148	CbGpPWpGaD
Vincristine—TUBB4B—G2/M Transition—EP300—ocular cancer	5.84e-05	0.00145	CbGpPWpGaD
Vincristine—TUBA4A—Cell Cycle—CDKN2B—ocular cancer	5.8e-05	0.00144	CbGpPWpGaD
Vincristine—ABCB11—Metabolism—PSPH—ocular cancer	5.77e-05	0.00144	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—TFDP1—ocular cancer	5.77e-05	0.00144	CbGpPWpGaD
Vincristine—TUBB4B—Mitotic G2-G2/M phases—EP300—ocular cancer	5.76e-05	0.00143	CbGpPWpGaD
Vincristine—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—ocular cancer	5.58e-05	0.00139	CbGpPWpGaD
Vincristine—ABCC3—Metabolism—PSPH—ocular cancer	5.53e-05	0.00138	CbGpPWpGaD
Vincristine—TUBB—Cell Cycle, Mitotic—CDKN2B—ocular cancer	5.51e-05	0.00137	CbGpPWpGaD
Vincristine—TUBB—Cell Cycle—HDAC1—ocular cancer	5.5e-05	0.00137	CbGpPWpGaD
Vincristine—TUBB—Cell Cycle—CCND2—ocular cancer	5.5e-05	0.00137	CbGpPWpGaD
Vincristine—TUBB4B—Cell Cycle, Mitotic—CDK6—ocular cancer	5.42e-05	0.00135	CbGpPWpGaD
Vincristine—TUBA4A—Cell Cycle—E2F1—ocular cancer	5.32e-05	0.00133	CbGpPWpGaD
Vincristine—TUBB4A—Cell Cycle—CDK6—ocular cancer	5.3e-05	0.00132	CbGpPWpGaD
Vincristine—TUBA4A—Cell Cycle, Mitotic—CDK2—ocular cancer	5.13e-05	0.00128	CbGpPWpGaD
Vincristine—TUBB4A—Cell Cycle, Mitotic—CCND2—ocular cancer	5.1e-05	0.00127	CbGpPWpGaD
Vincristine—TUBB4A—Cell Cycle, Mitotic—HDAC1—ocular cancer	5.1e-05	0.00127	CbGpPWpGaD
Vincristine—TUBB—Cell Cycle, Mitotic—E2F1—ocular cancer	5.06e-05	0.00126	CbGpPWpGaD
Vincristine—ABCG2—HIF-1-alpha transcription factor network—EP300—ocular cancer	5.05e-05	0.00126	CbGpPWpGaD
Vincristine—TUBB—Cell Cycle—CDKN2B—ocular cancer	4.93e-05	0.00123	CbGpPWpGaD
Vincristine—ABCB1—retina—ocular cancer	4.93e-05	0.0101	CbGeAlD
Vincristine—TUBA4A—Hemostasis—CDK2—ocular cancer	4.86e-05	0.00121	CbGpPWpGaD
Vincristine—TUBA4A—Cell Cycle, Mitotic—CDK4—ocular cancer	4.85e-05	0.00121	CbGpPWpGaD
Vincristine—NR0B1—Gene Expression—HDAC1—ocular cancer	4.85e-05	0.00121	CbGpPWpGaD
Vincristine—TUBB4B—Cell Cycle—CDK6—ocular cancer	4.85e-05	0.00121	CbGpPWpGaD
Vincristine—TUBB4B—Cell Cycle, Mitotic—CCND2—ocular cancer	4.66e-05	0.00116	CbGpPWpGaD
Vincristine—TUBB4B—Cell Cycle, Mitotic—HDAC1—ocular cancer	4.66e-05	0.00116	CbGpPWpGaD
Vincristine—TUBA4A—Platelet activation, signaling and aggregation—TGFB1—ocular cancer	4.61e-05	0.00115	CbGpPWpGaD
Vincristine—TUBA4A—Cell Cycle—CDK2—ocular cancer	4.59e-05	0.00114	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—MAML2—ocular cancer	4.58e-05	0.00114	CbGpPWpGaD
Vincristine—TUBB4A—Cell Cycle, Mitotic—CDKN2B—ocular cancer	4.57e-05	0.00114	CbGpPWpGaD
Vincristine—TUBB4A—Cell Cycle—CCND2—ocular cancer	4.56e-05	0.00113	CbGpPWpGaD
Vincristine—TUBB4A—Cell Cycle—HDAC1—ocular cancer	4.56e-05	0.00113	CbGpPWpGaD
Vincristine—ABCB1—epithelium—ocular cancer	4.55e-05	0.00928	CbGeAlD
Vincristine—TUBB—Cell Cycle—E2F1—ocular cancer	4.52e-05	0.00113	CbGpPWpGaD
Vincristine—TUBB—Cell Cycle, Mitotic—CDK2—ocular cancer	4.36e-05	0.00109	CbGpPWpGaD
Vincristine—NR0B1—Gene Expression—CDKN2B—ocular cancer	4.34e-05	0.00108	CbGpPWpGaD
Vincristine—TUBA4A—Cell Cycle—CDK4—ocular cancer	4.34e-05	0.00108	CbGpPWpGaD
Vincristine—ABCC1—Metabolism—PSPH—ocular cancer	4.34e-05	0.00108	CbGpPWpGaD
Vincristine—TUBA4A—Cell Cycle, Mitotic—RB1—ocular cancer	4.22e-05	0.00105	CbGpPWpGaD
Vincristine—TUBB4A—Cell Cycle, Mitotic—E2F1—ocular cancer	4.19e-05	0.00104	CbGpPWpGaD
Vincristine—TUBB4B—Cell Cycle, Mitotic—CDKN2B—ocular cancer	4.18e-05	0.00104	CbGpPWpGaD
Vincristine—TUBB4B—Cell Cycle—HDAC1—ocular cancer	4.17e-05	0.00104	CbGpPWpGaD
Vincristine—TUBB4B—Cell Cycle—CCND2—ocular cancer	4.17e-05	0.00104	CbGpPWpGaD
Vincristine—TUBB—Cell Cycle, Mitotic—CDK4—ocular cancer	4.12e-05	0.00103	CbGpPWpGaD
Vincristine—TUBB4A—Cell Cycle—CDKN2B—ocular cancer	4.08e-05	0.00102	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—GNA11—ocular cancer	4e-05	0.000996	CbGpPWpGaD
Vincristine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—ocular cancer	3.94e-05	0.000982	CbGpPWpGaD
Vincristine—TUBB—Cell Cycle—CDK2—ocular cancer	3.9e-05	0.000972	CbGpPWpGaD
Vincristine—TUBB4B—Cell Cycle, Mitotic—E2F1—ocular cancer	3.83e-05	0.000955	CbGpPWpGaD
Vincristine—ABCG2—Metabolism—PSPH—ocular cancer	3.82e-05	0.00095	CbGpPWpGaD
Vincristine—CYP3A7—Metabolism—PSPH—ocular cancer	3.78e-05	0.000942	CbGpPWpGaD
Vincristine—TUBA4A—Cell Cycle—RB1—ocular cancer	3.77e-05	0.000939	CbGpPWpGaD
Vincristine—TUBB4A—Cell Cycle—E2F1—ocular cancer	3.75e-05	0.000934	CbGpPWpGaD
Vincristine—TUBB4B—Cell Cycle—CDKN2B—ocular cancer	3.74e-05	0.000931	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—GNAQ—ocular cancer	3.72e-05	0.000926	CbGpPWpGaD
Vincristine—TUBB—Cell Cycle—CDK4—ocular cancer	3.69e-05	0.000919	CbGpPWpGaD
Vincristine—TUBB4A—Cell Cycle, Mitotic—CDK2—ocular cancer	3.62e-05	0.000901	CbGpPWpGaD
Vincristine—TUBB—Cell Cycle, Mitotic—RB1—ocular cancer	3.59e-05	0.000893	CbGpPWpGaD
Vincristine—ABCB1—lymphoid tissue—ocular cancer	3.5e-05	0.00715	CbGeAlD
Vincristine—NR0B1—Generic Transcription Pathway—MYC—ocular cancer	3.5e-05	0.000871	CbGpPWpGaD
Vincristine—ABCC1—Disease—SAG—ocular cancer	3.43e-05	0.000854	CbGpPWpGaD
Vincristine—TUBB4B—Cell Cycle—E2F1—ocular cancer	3.43e-05	0.000854	CbGpPWpGaD
Vincristine—TUBB4A—Cell Cycle, Mitotic—CDK4—ocular cancer	3.42e-05	0.000851	CbGpPWpGaD
Vincristine—ABCC3—NRF2 pathway—TGFB1—ocular cancer	3.37e-05	0.00084	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—HDAC1—ocular cancer	3.35e-05	0.000835	CbGpPWpGaD
Vincristine—TUBB4B—Cell Cycle, Mitotic—CDK2—ocular cancer	3.31e-05	0.000824	CbGpPWpGaD
Vincristine—TUBA4A—Cell Cycle, Mitotic—CDKN1B—ocular cancer	3.28e-05	0.000818	CbGpPWpGaD
Vincristine—TUBB4A—Cell Cycle—CDK2—ocular cancer	3.23e-05	0.000805	CbGpPWpGaD
Vincristine—TUBA4A—Cell Cycle—MDM2—ocular cancer	3.22e-05	0.000801	CbGpPWpGaD
Vincristine—TUBB—Cell Cycle—RB1—ocular cancer	3.21e-05	0.000799	CbGpPWpGaD
Vincristine—TUBA4A—Platelet activation, signaling and aggregation—AKT1—ocular cancer	3.2e-05	0.000798	CbGpPWpGaD
Vincristine—TUBA4A—Cell Cycle, Mitotic—CCND1—ocular cancer	3.13e-05	0.00078	CbGpPWpGaD
Vincristine—TUBB4B—Cell Cycle, Mitotic—CDK4—ocular cancer	3.13e-05	0.000779	CbGpPWpGaD
Vincristine—TUBB4A—Cell Cycle—CDK4—ocular cancer	3.06e-05	0.000761	CbGpPWpGaD
Vincristine—ABCG2—HIF-1-alpha transcription factor network—AKT1—ocular cancer	3.05e-05	0.00076	CbGpPWpGaD
Vincristine—ABCC1—Disease—E2F5—ocular cancer	3.04e-05	0.000756	CbGpPWpGaD
Vincristine—TUBA4A—Cell Cycle, Mitotic—CDKN1A—ocular cancer	3.03e-05	0.000755	CbGpPWpGaD
Vincristine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—ocular cancer	3.02e-05	0.000752	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—CDKN2B—ocular cancer	3e-05	0.000748	CbGpPWpGaD
Vincristine—ABCC1—Disease—E2F4—ocular cancer	2.97e-05	0.000741	CbGpPWpGaD
Vincristine—TUBB4A—Cell Cycle, Mitotic—RB1—ocular cancer	2.97e-05	0.00074	CbGpPWpGaD
Vincristine—TUBB4B—Cell Cycle—CDK2—ocular cancer	2.96e-05	0.000737	CbGpPWpGaD
Vincristine—TUBA4A—Cell Cycle—CDKN1B—ocular cancer	2.94e-05	0.000731	CbGpPWpGaD
Vincristine—ABCC1—Disease—RBL1—ocular cancer	2.92e-05	0.000726	CbGpPWpGaD
Vincristine—ABCC1—Disease—RPL39—ocular cancer	2.92e-05	0.000726	CbGpPWpGaD
Vincristine—TUBA4A—Cell Cycle, Mitotic—EP300—ocular cancer	2.88e-05	0.000718	CbGpPWpGaD
Vincristine—TUBA4A—Cell Cycle—CCND1—ocular cancer	2.8e-05	0.000698	CbGpPWpGaD
Vincristine—CYP3A4—Tryptophan metabolism—MDM2—ocular cancer	2.8e-05	0.000697	CbGpPWpGaD
Vincristine—TUBB4B—Cell Cycle—CDK4—ocular cancer	2.79e-05	0.000696	CbGpPWpGaD
Vincristine—TUBB—Cell Cycle, Mitotic—CDKN1B—ocular cancer	2.79e-05	0.000695	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—E2F1—ocular cancer	2.76e-05	0.000687	CbGpPWpGaD
Vincristine—TUBB—Cell Cycle—MDM2—ocular cancer	2.73e-05	0.000681	CbGpPWpGaD
Vincristine—CYP3A5—Metabolism—PSPH—ocular cancer	2.73e-05	0.000681	CbGpPWpGaD
Vincristine—TUBA4A—Hemostasis—EP300—ocular cancer	2.73e-05	0.00068	CbGpPWpGaD
Vincristine—ABCB1—HIF-1-alpha transcription factor network—EP300—ocular cancer	2.73e-05	0.00068	CbGpPWpGaD
Vincristine—TUBB4B—Cell Cycle, Mitotic—RB1—ocular cancer	2.72e-05	0.000677	CbGpPWpGaD
Vincristine—TUBA4A—Cell Cycle—CDKN1A—ocular cancer	2.71e-05	0.000675	CbGpPWpGaD
Vincristine—ABCC2—NRF2 pathway—TGFB1—ocular cancer	2.67e-05	0.000666	CbGpPWpGaD
Vincristine—TUBB—Cell Cycle, Mitotic—CCND1—ocular cancer	2.66e-05	0.000663	CbGpPWpGaD
Vincristine—TUBB4A—Cell Cycle—RB1—ocular cancer	2.66e-05	0.000662	CbGpPWpGaD
Vincristine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—ocular cancer	2.62e-05	0.000653	CbGpPWpGaD
Vincristine—TUBA4A—Cell Cycle—EP300—ocular cancer	2.58e-05	0.000642	CbGpPWpGaD
Vincristine—TUBB—Cell Cycle, Mitotic—CDKN1A—ocular cancer	2.58e-05	0.000642	CbGpPWpGaD
Vincristine—TUBA4A—Cell Cycle, Mitotic—MYC—ocular cancer	2.51e-05	0.000626	CbGpPWpGaD
Vincristine—TUBB—Cell Cycle—CDKN1B—ocular cancer	2.5e-05	0.000622	CbGpPWpGaD
Vincristine—TUBB—Cell Cycle, Mitotic—EP300—ocular cancer	2.45e-05	0.000611	CbGpPWpGaD
Vincristine—TUBB4B—Cell Cycle—RB1—ocular cancer	2.43e-05	0.000605	CbGpPWpGaD
Vincristine—ABCB1—Integrated Pancreatic Cancer Pathway—E2F1—ocular cancer	2.41e-05	0.0006	CbGpPWpGaD
Vincristine—TUBB—Cell Cycle—CCND1—ocular cancer	2.38e-05	0.000593	CbGpPWpGaD
Vincristine—TUBA4A—Hemostasis—TGFB1—ocular cancer	2.37e-05	0.000592	CbGpPWpGaD
Vincristine—ABCC1—Disease—TFDP1—ocular cancer	2.35e-05	0.000586	CbGpPWpGaD
Vincristine—TUBB4A—Cell Cycle, Mitotic—CDKN1B—ocular cancer	2.31e-05	0.000576	CbGpPWpGaD
Vincristine—TUBB—Cell Cycle—CDKN1A—ocular cancer	2.3e-05	0.000574	CbGpPWpGaD
Vincristine—TUBB4A—Cell Cycle—MDM2—ocular cancer	2.27e-05	0.000564	CbGpPWpGaD
Vincristine—TUBA4A—Cell Cycle—MYC—ocular cancer	2.25e-05	0.00056	CbGpPWpGaD
Vincristine—TUBB4A—Cell Cycle, Mitotic—CCND1—ocular cancer	2.21e-05	0.00055	CbGpPWpGaD
Vincristine—TUBB—Cell Cycle—EP300—ocular cancer	2.19e-05	0.000546	CbGpPWpGaD
Vincristine—TUBB—Cell Cycle, Mitotic—MYC—ocular cancer	2.14e-05	0.000532	CbGpPWpGaD
Vincristine—TUBB4A—Cell Cycle, Mitotic—CDKN1A—ocular cancer	2.13e-05	0.000532	CbGpPWpGaD
Vincristine—TUBB4B—Cell Cycle, Mitotic—CDKN1B—ocular cancer	2.12e-05	0.000527	CbGpPWpGaD
Vincristine—ABCB1—Integrated Pancreatic Cancer Pathway—CDK2—ocular cancer	2.08e-05	0.000517	CbGpPWpGaD
Vincristine—TUBB4B—Cell Cycle—MDM2—ocular cancer	2.07e-05	0.000516	CbGpPWpGaD
Vincristine—TUBB4A—Cell Cycle—CDKN1B—ocular cancer	2.07e-05	0.000515	CbGpPWpGaD
Vincristine—ABCB1—Metabolism—PSPH—ocular cancer	2.06e-05	0.000514	CbGpPWpGaD
Vincristine—ABCB1—Allograft Rejection—TGFB1—ocular cancer	2.05e-05	0.000512	CbGpPWpGaD
Vincristine—TUBB4A—Cell Cycle, Mitotic—EP300—ocular cancer	2.03e-05	0.000506	CbGpPWpGaD
Vincristine—TUBB4B—Cell Cycle, Mitotic—CCND1—ocular cancer	2.02e-05	0.000503	CbGpPWpGaD
Vincristine—TUBB4A—Cell Cycle—CCND1—ocular cancer	1.97e-05	0.000492	CbGpPWpGaD
Vincristine—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—ocular cancer	1.96e-05	0.000489	CbGpPWpGaD
Vincristine—TUBA4A—Hemostasis—TP53—ocular cancer	1.95e-05	0.000487	CbGpPWpGaD
Vincristine—TUBB4B—Cell Cycle, Mitotic—CDKN1A—ocular cancer	1.95e-05	0.000486	CbGpPWpGaD
Vincristine—TUBB—Cell Cycle—MYC—ocular cancer	1.91e-05	0.000476	CbGpPWpGaD
Vincristine—TUBB4A—Cell Cycle—CDKN1A—ocular cancer	1.91e-05	0.000476	CbGpPWpGaD
Vincristine—SLC22A3—Metabolism—GNA11—ocular cancer	1.89e-05	0.000472	CbGpPWpGaD
Vincristine—TUBB4B—Cell Cycle—CDKN1B—ocular cancer	1.89e-05	0.000471	CbGpPWpGaD
Vincristine—TUBA4A—Hemostasis—HRAS—ocular cancer	1.87e-05	0.000466	CbGpPWpGaD
Vincristine—ABCC1—Disease—MAML2—ocular cancer	1.87e-05	0.000465	CbGpPWpGaD
Vincristine—TUBB4B—Cell Cycle, Mitotic—EP300—ocular cancer	1.86e-05	0.000463	CbGpPWpGaD
Vincristine—TUBA4A—Cell Cycle—TP53—ocular cancer	1.84e-05	0.00046	CbGpPWpGaD
Vincristine—ABCB11—Metabolism—GNA11—ocular cancer	1.82e-05	0.000452	CbGpPWpGaD
Vincristine—TUBB4A—Cell Cycle—EP300—ocular cancer	1.82e-05	0.000452	CbGpPWpGaD
Vincristine—TUBB4B—Cell Cycle—CCND1—ocular cancer	1.8e-05	0.00045	CbGpPWpGaD
Vincristine—TUBB4A—Cell Cycle, Mitotic—MYC—ocular cancer	1.77e-05	0.000441	CbGpPWpGaD
Vincristine—SLC22A3—Metabolism—GNAQ—ocular cancer	1.76e-05	0.000439	CbGpPWpGaD
Vincristine—TUBB4B—Cell Cycle—CDKN1A—ocular cancer	1.75e-05	0.000435	CbGpPWpGaD
Vincristine—ABCC3—Metabolism—GNA11—ocular cancer	1.74e-05	0.000434	CbGpPWpGaD
Vincristine—ABCB11—Metabolism—GNAQ—ocular cancer	1.69e-05	0.000421	CbGpPWpGaD
Vincristine—NR0B1—Gene Expression—MYC—ocular cancer	1.68e-05	0.000419	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—MDM2—ocular cancer	1.67e-05	0.000415	CbGpPWpGaD
Vincristine—TUBB4B—Cell Cycle—EP300—ocular cancer	1.66e-05	0.000414	CbGpPWpGaD
Vincristine—TUBA4A—Hemostasis—AKT1—ocular cancer	1.65e-05	0.000411	CbGpPWpGaD
Vincristine—ABCB1—HIF-1-alpha transcription factor network—AKT1—ocular cancer	1.65e-05	0.000411	CbGpPWpGaD
Vincristine—ABCC3—Metabolism—GNAQ—ocular cancer	1.62e-05	0.000403	CbGpPWpGaD
Vincristine—TUBB4B—Cell Cycle, Mitotic—MYC—ocular cancer	1.62e-05	0.000403	CbGpPWpGaD
Vincristine—TUBB4A—Cell Cycle—MYC—ocular cancer	1.58e-05	0.000394	CbGpPWpGaD
Vincristine—TUBB—Cell Cycle—TP53—ocular cancer	1.57e-05	0.000391	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—CDKN1B—ocular cancer	1.52e-05	0.000379	CbGpPWpGaD
Vincristine—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—ocular cancer	1.45e-05	0.000362	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—CCND1—ocular cancer	1.45e-05	0.000362	CbGpPWpGaD
Vincristine—TUBB4B—Cell Cycle—MYC—ocular cancer	1.45e-05	0.000361	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—CDKN1A—ocular cancer	1.4e-05	0.00035	CbGpPWpGaD
Vincristine—ABCC1—Disease—HDAC1—ocular cancer	1.37e-05	0.00034	CbGpPWpGaD
Vincristine—ABCC1—Metabolism—GNA11—ocular cancer	1.36e-05	0.00034	CbGpPWpGaD
Vincristine—ABCB11—Metabolism of lipids and lipoproteins—EP300—ocular cancer	1.36e-05	0.000339	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—EP300—ocular cancer	1.34e-05	0.000333	CbGpPWpGaD
Vincristine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—ocular cancer	1.33e-05	0.000331	CbGpPWpGaD
Vincristine—ABCC3—Metabolism of lipids and lipoproteins—EP300—ocular cancer	1.31e-05	0.000325	CbGpPWpGaD
Vincristine—TUBB4A—Cell Cycle—TP53—ocular cancer	1.3e-05	0.000324	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—PSPH—ocular cancer	1.27e-05	0.000317	CbGpPWpGaD
Vincristine—ABCC1—Metabolism—GNAQ—ocular cancer	1.27e-05	0.000316	CbGpPWpGaD
Vincristine—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—ocular cancer	1.27e-05	0.000316	CbGpPWpGaD
Vincristine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—ocular cancer	1.23e-05	0.000305	CbGpPWpGaD
Vincristine—ABCC1—Disease—CDKN2B—ocular cancer	1.22e-05	0.000305	CbGpPWpGaD
Vincristine—ABCG2—Metabolism—GNA11—ocular cancer	1.2e-05	0.000299	CbGpPWpGaD
Vincristine—CYP3A7—Metabolism—GNA11—ocular cancer	1.19e-05	0.000296	CbGpPWpGaD
Vincristine—TUBB4B—Cell Cycle—TP53—ocular cancer	1.19e-05	0.000296	CbGpPWpGaD
Vincristine—NR0B1—Gene Expression—AKT1—ocular cancer	1.17e-05	0.000291	CbGpPWpGaD
Vincristine—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—ocular cancer	1.17e-05	0.000291	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—MYC—ocular cancer	1.16e-05	0.00029	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—TGFB1—ocular cancer	1.16e-05	0.000289	CbGpPWpGaD
Vincristine—ABCG2—Metabolism—GNAQ—ocular cancer	1.12e-05	0.000278	CbGpPWpGaD
Vincristine—CYP3A7—Metabolism—GNAQ—ocular cancer	1.11e-05	0.000276	CbGpPWpGaD
Vincristine—ABCC1—Metabolism of lipids and lipoproteins—EP300—ocular cancer	1.02e-05	0.000255	CbGpPWpGaD
Vincristine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—ocular cancer	1.02e-05	0.000253	CbGpPWpGaD
Vincristine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—ocular cancer	1.01e-05	0.000253	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—TP53—ocular cancer	9.56e-06	0.000238	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—HRAS—ocular cancer	9.14e-06	0.000228	CbGpPWpGaD
Vincristine—CYP3A5—Metabolism—GNA11—ocular cancer	8.6e-06	0.000214	CbGpPWpGaD
Vincristine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—ocular cancer	8.35e-06	0.000208	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—AKT1—ocular cancer	8.07e-06	0.000201	CbGpPWpGaD
Vincristine—CYP3A5—Metabolism—GNAQ—ocular cancer	8e-06	0.000199	CbGpPWpGaD
Vincristine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—ocular cancer	7.05e-06	0.000176	CbGpPWpGaD
Vincristine—ABCC1—Disease—MDM2—ocular cancer	6.79e-06	0.000169	CbGpPWpGaD
Vincristine—ABCB1—Metabolism—GNA11—ocular cancer	6.49e-06	0.000162	CbGpPWpGaD
Vincristine—SLC22A3—Metabolism—EP300—ocular cancer	6.33e-06	0.000158	CbGpPWpGaD
Vincristine—ABCC1—Disease—CDKN1B—ocular cancer	6.2e-06	0.000154	CbGpPWpGaD
Vincristine—ABCB11—Metabolism—EP300—ocular cancer	6.07e-06	0.000151	CbGpPWpGaD
Vincristine—ABCB1—Metabolism—GNAQ—ocular cancer	6.03e-06	0.00015	CbGpPWpGaD
Vincristine—ABCC3—Metabolism—EP300—ocular cancer	5.82e-06	0.000145	CbGpPWpGaD
Vincristine—ABCC1—Disease—CDKN1A—ocular cancer	5.72e-06	0.000143	CbGpPWpGaD
Vincristine—ABCC1—Disease—EP300—ocular cancer	5.44e-06	0.000136	CbGpPWpGaD
Vincristine—ABCC1—Disease—MYC—ocular cancer	4.74e-06	0.000118	CbGpPWpGaD
Vincristine—ABCC1—Disease—TGFB1—ocular cancer	4.73e-06	0.000118	CbGpPWpGaD
Vincristine—ABCC1—Metabolism—EP300—ocular cancer	4.56e-06	0.000114	CbGpPWpGaD
Vincristine—ABCG2—Metabolism—EP300—ocular cancer	4.01e-06	9.99e-05	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—GNA11—ocular cancer	4e-06	9.96e-05	CbGpPWpGaD
Vincristine—CYP3A7—Metabolism—EP300—ocular cancer	3.98e-06	9.9e-05	CbGpPWpGaD
Vincristine—SLC22A3—Metabolism—AKT1—ocular cancer	3.83e-06	9.53e-05	CbGpPWpGaD
Vincristine—ABCC1—Disease—HRAS—ocular cancer	3.73e-06	9.28e-05	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—GNAQ—ocular cancer	3.72e-06	9.26e-05	CbGpPWpGaD
Vincristine—ABCB11—Metabolism—AKT1—ocular cancer	3.67e-06	9.14e-05	CbGpPWpGaD
Vincristine—ABCC3—Metabolism—AKT1—ocular cancer	3.52e-06	8.76e-05	CbGpPWpGaD
Vincristine—ABCC1—Disease—AKT1—ocular cancer	3.29e-06	8.19e-05	CbGpPWpGaD
Vincristine—CYP3A5—Metabolism—EP300—ocular cancer	2.87e-06	7.16e-05	CbGpPWpGaD
Vincristine—ABCC1—Metabolism—AKT1—ocular cancer	2.75e-06	6.86e-05	CbGpPWpGaD
Vincristine—ABCG2—Metabolism—AKT1—ocular cancer	2.42e-06	6.04e-05	CbGpPWpGaD
Vincristine—CYP3A7—Metabolism—AKT1—ocular cancer	2.4e-06	5.99e-05	CbGpPWpGaD
Vincristine—ABCB1—Metabolism—EP300—ocular cancer	2.17e-06	5.4e-05	CbGpPWpGaD
Vincristine—CYP3A5—Metabolism—AKT1—ocular cancer	1.74e-06	4.33e-05	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—EP300—ocular cancer	1.34e-06	3.33e-05	CbGpPWpGaD
Vincristine—ABCB1—Metabolism—AKT1—ocular cancer	1.31e-06	3.26e-05	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—AKT1—ocular cancer	8.07e-07	2.01e-05	CbGpPWpGaD
